Disease Overview：Chromosome Karyotype Analysis（Karyotyping）
Chromosome karyotype analysis is not a disease but a diagnostic cytogenetic procedure used primarily in hematology to detect numerical and structural chromosomal abnormalities—such as aneuploidy, translocations (e.g., Philadelphia chromosome in CML), deletions, duplications, or inversions—in peripheral blood or bone marrow specimens. It remains the gold standard for initial genomic assessment in hematologic malignancies including acute myeloid leukemia (AML), chronic lymphocytic leukemia (CLL), myelodysplastic syndromes (MDS), and lymphomas. Performed via G-banding after lymphocyte culture and metaphase arrest, it provides a genome-wide view at 400–550-band resolution, enabling risk stratification, therapeutic decision-making, and monitoring of clonal evolution. While newer techniques like FISH and NGS offer higher sensitivity for specific targets, karyotyping retains irreplaceable value in detecting unexpected or complex rearrangements.
China offers distinct advantages for this diagnostic service: Tier-1 hospitals employ certified clinical cytogeneticists with extensive experience in WHO-classified hematologic disorders; state-of-the-art automated imaging systems (e.g., MetaSystems ChromoVision) ensure high-resolution analysis and reproducibility; over 98% of routine karyotypes are reported within 7–10 working days, with documented concordance rates exceeding 99.2% across major centers. Costs average 30–50% lower than in the US or EU, without compromising CLIA/CAP-equivalent quality standards. As a dedicated medical tourism agency, we facilitate seamless access—vetting accredited laboratories, coordinating specimen logistics or in-person evaluations, providing itemized, transparent pricing, and offering end-to-end support from documentation assistance to post-report consultation.
Medical Treatment Guide
Treatment Options & Itemized Cost Breakdown: Chromosomal Karyotype Analysis (Hematology)
Chromosomal karyotype analysis is a diagnostic cytogenetic test, not a therapeutic intervention. It identifies numerical/structural chromosomal abnormalities in hematopoietic cells (e.g., in leukemia, MDS, lymphoma, or unexplained cytopenias). Treatment decisions *follow* results—not vice versa. Below is the accurate diagnostic pathway and associated costs.
Non-Surgical / Diagnostic Options
*Target Criteria:* Suspected hematologic malignancy, clonal hematopoiesis, therapy-related myeloid neoplasm, or constitutional cytogenetic disorder evaluation.
- •Standard G-Banded Karyotype (20 metaphases)
- Tier 1 (Public Tertiary Hospital): $380–$420 - Tier 2 (Specialized Hematology Center): $450–$490 - Includes: Culture reagents, microscope time, certified cytogeneticist interpretation
- •Rapid FISH Panel (3–5 probes, e.g., BCR::ABL1, PML::RARA, TP53, CEP8)
- Fee: $210–$260 (per probe set; add $65/probe beyond base panel)
- •Pre-Analytical Fees (Mandatory)
- Complete blood count + peripheral smear review: $25–$35 - Coagulation panel (PT/aPTT): $30–$40
Procedural / Interventional Options
*Eligibility:* Patients requiring bone marrow sampling for karyotype—no surgical “treatment” exists for karyotype analysis itself.
- •Bone Marrow Biopsy + Aspirate (for concurrent histopathology + cytogenetics)
- Procedure fee (Grade 3A hospital): $290–$330 - Preoperative checks (mandatory): CBC ($25), PT/INR ($30), chest X-ray ($45), ECG ($35) → Total pre-op: $135
Special / Complex Condition Costs
- •High-Resolution Karyotype (400–550 band level, ≥50 metaphases)
- Fee: $680–$740
- •Karyotype + SNP-Array Integration
- Fee: $1,120–$1,260 (includes bioinformatics validation)
- •Urgent STAT Karyotype (48h turnaround)
- Surcharge: +$320 on standard karyotype
Quick Selection Guide
- •Newly diagnosed AML/ALL (age <60, no comorbidities): Standard karyotype + rapid FISH panel ($620–$750) — optimal balance of speed, sensitivity, and cost.
- •Elderly MDS patient (age ≥75, cardiac comorbidity): Standard karyotype only ($400) — avoids unnecessary FISH probes; biopsy risk outweighs incremental yield.
- •Relapsed/refractory AML with complex karyotype: High-resolution karyotype + SNP-array ($1,800–$2,000) — essential for identifying targetable lesions (e.g., TP53 LOH) and transplant eligibility.
- •Budget-constrained outpatient (suspected CML): Rapid FISH for BCR::ABL1 alone ($220) — sufficient for initial diagnosis; confirmatory karyotype deferred until treatment initiation.
Pricing & Service Differences: International / VIP Dept vs. Regular Clinic
International Medical Services (IMS / VIP Departments) at Grade-3A public hospitals and private international clinics operate under self-regulated VIP fee schedules. Fees are higher than standard public clinics (which are subsidized solely for domestic citizens and do not accept overseas insurances). In exchange, international patients receive 6 exclusive medical privileges:
Recommended Hospitals
Explore selected Grade 3A public hospitals in China with rich clinical experience for this condition:
🌴 Recommended Chromosome Karyotype Analysis Medical Vacation Packages
Curated transparent all-inclusive packages combining Chromosome Karyotype Analysis treatment with China top medical destinations:
